Oncopeptides AB (publ)

BATS-CHIXE:ONCOS Stock Report

Market Cap: SEK 942.1m

Oncopeptides Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Monica Shaw

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure1.5yrs
Board average tenure5.7yrs

Recent management updates

Recent updates

CEO

Monica Shaw (44 yo)

less than a year

Tenure

Dr. Monica Shaw, M.D., serves as Independent Non-Executive Director of AC Immune SA since October 2021. She serves as Chief Executive Officer in Oncopeptides AB (publ) since January 04, 2023. She was Execu...

Leadership Team

NamePositionTenureCompensationOwnership
Jakob Lindberg
Chief Scientific Officerless than a yearSEK 11.12m0.92%
SEK 8.7m
Monica Shaw
Chief Executive Officerless than a yearno datano data
Rolf Larsson
Founderno datano datano data
Rolf Lewensohn
Founderno datano datano data
Joachim Gullbo
Founderno datano datano data
Kristina Luthman
Founderno datano datano data
Hans Ehrsson
Founderno datano datano data
Peter Nygren
Founderno datano datano data
Holger Lembrer
Chief Financial Officerless than a yearno datano data
Eva Nordström
COO & Deputy MD3.4yrsno data0.13%
SEK 1.2m
Linda Holmstrom
Director of Investor Relations2.5yrsno datano data
Sara Svardgren
Head of Human Resources5.1yrsno datano data

1.5yrs

Average Tenure

47.5yo

Average Age

Experienced Management: ONCOS's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Per Wold-Olsen
Independent Chairman of the Board5.1yrsSEK 1.54m0.091%
SEK 858.3k
Per Anders Samuelsson
Director11.4yrsSEK 347.00kno data
Cecilia Wennborg
Independent Director6.3yrsSEK 645.00k0.013%
SEK 117.9k
Lori Kunkel
Member of Clinical Advisory Boardno datano datano data
Jarl Jungnelius
Independent Director12.2yrsSEK 581.00k0.061%
SEK 576.9k
Brian Stuglik
Independent Director5.1yrsSEK 709.00kno data
Christian Jacques
Member of Clinical Advisory Boardno datano datano data
Jennifer Jackson
Independent Director4.5yrsSEK 703.00kno data
Axel Glasmacher
Member of Clinical Advisory Boardno datano datano data
Paul Richardson
Member of Clinical Advisory Boardno datano datano data

5.7yrs

Average Tenure

65yo

Average Age

Experienced Board: ONCOS's board of directors are considered experienced (5.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/06/24 16:55
End of Day Share Price 2023/03/27 00:00
Earnings2023/03/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Oncopeptides AB (publ) is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Erik HultgårdCarnegie Investment Bank AB
Patrik LingDNB Markets
Peter WelfordJefferies LLC